Renin inhibitor in plasma of uraemic patients.
D000293:Adolescent; D000328:Adult; D000804:Angiotensin II / Q000096:biosynthesis; D005260:Female; D005921:Glomerulonephritis / Q000150:complications; D006801:Humans; D006973:Hypertension / Q000097:blood; D006974:Hypertension, Malignant / Q000097:blood; D006977:Hypertension, Renal / Q000097:blood; D007676:Kidney Failure, Chronic / Q000097:blood; D008297:Male; D008875:Middle Aged; D010673:Pheochromocytoma / Q000097:blood; D010949:Plasma; D012083:Renin / Q000097:blood; D012965:Sodium Chloride; D014511:Uremia / Q000097:blood*; D000092502:Renin Inhibitors
D000804:Angiotensin II; D012083:Renin; D012965:Sodium Chloride; D000092502:Renin Inhibitors